Vol 6 (October 30, 2025): Translational Breast Cancer Research

Axillary management in patients with sentinel lymph node micrometastases following neoadjuvant systemic therapy: a call for de-escalation

Methodological considerations in predicting axillary residual disease using imaging features

Could circulating tumor cells explain why breast conservation improves survival despite higher locoregional recurrence?

TARGIT-IORT in early breast cancer—real world evidence for a risk-adapted approach

CHEK2 variants, breast cancer, and implications for management: a narrative review

Precision diagnosis and treatment of PI3K/AKT/PTEN signaling pathway in HR-positive advanced breast cancer: perspectives from Chinese experts

Organoids in breast cancer translational research: intersection of technologies

Patient outcomes and clinician perspectives following one year of ad hoc implementation of neoadjuvant endocrine therapy in early breast cancer

Predictive potential of hepatocyte growth factor and bone morphogenetic proteins in lymphatic metastasis of breast cancer

The impact and mechanisms of CRIP2 on the biological behavior of triple-negative breast cancer cells

Combined treatment of inetetamab plus pyrotinib and vinorelbine in managing advanced HER2-positive breast cancer patients (ILLUMINE): a multicenter, retrospective, real-world study